|Year : 2014 | Volume
| Issue : 1 | Page : 3-7
Role of indigenous herbs in the management of Alzheimer's disease
K Nishteswar1, Hemang Joshi2, Rahul Dutt Karra3
1 Department of Dravyaguna, Institute for Post Graduate Teaching and Research in Ayurveda, Jamnagar, Gujarat, India
2 Institute of Ayurvedic Pharmaceutical Sciences, Gujarat Ayurved University, Jamnagar, Gujarat, India
3 Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, Gujarat, India
|Date of Web Publication||4-Feb-2015|
Department of Dravyguna, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamngar - 361 008, Gujarat
Source of Support: None, Conflict of Interest: None
Ageing is a natural phenomenon and decline of physiological and structural changes are incurable in advancing years of human life. When such degenerative changes occur in the brain they may lead to dementia and other memory related conditions. The Ayurvedic classics identified the importance of higher faculties dealing with memory and introduced a separate group of drugs namely Medhya Rasayanas. Regular intake of such drugs will help to prevent the onset of degenerative changes in the brain prematurely. Ayurveda can play a useful role in the management of such geriatric conditions. The current review has been done with a view to update documented Ayurvedic therapeutic modalities for certain geriatric conditions suggested by Ayurvedic classics in the management of diseases called Vātavyādhi (nervous system disorders), which also include conditions related to memory functions. Recent studies have started validating the claims recorded in Ayurvedic texts. The pathogenesis and remedies for Vātavyādhi documented in Ayurvedic classics have been reviewed with special emphasis on disorders related to dementia. A review of recent researches on the herbs mentioned in management of vāta disorders including dementia have been done to understand their role in management of Alzheimer's disease (AD). There are many herbs of ethno-medicinal source studied experimentally for their potential in treatment of AD. A judicious combination of modern research methodology and Ayurvedic principles could go a long way in the management and care of AD which is going to be a heavy burden on the society in the future.
Keywords: Alzheimer′s disease, cognitive disorders, memory enhancing drugs
|How to cite this article:|
Nishteswar K, Joshi H, Karra RD. Role of indigenous herbs in the management of Alzheimer's disease. Ancient Sci Life 2014;34:3-7
| Introduction|| |
Ageing is multi-factorial which reflects at cellular, organ and organism levels. Through advancements in modern medicine and technology more humans are surviving into later life with the potential to reach their technical life span of approximately 120 years of age.  However, part of the disability currently seen  in the elderly is due to lifestyle-induced diseases (for example, smoking related to heart disease and stroke). The elderly have a distinct spectrum of diseases which includes stroke, hypertension, coronary heart diseases, parkinsonism, osteoporosis, osteoarthritis, constipation, urinary incontinence, insomnia, vertigo, deafness and dementia including Alzheimer's disease (AD).
Until recently, cognitive decline was considered characteristic of normal ageing. In the past decade, the surveillance studies have noted that 15% of those over the age of 65 have moderate to severe dementia. AD once considered to be rare, is now recognized as the most common disorder of dementia. ,
Dementia is a chronic disorder in which there is progressive decline in intellect, behavior and personality.  Certain conditions such as AD, multi infarct dementia, uremia, chronic hepatic encephalopathy, thyroid/adrenal dysfunction, pernicious anemia, pellagra, brain tumors, subdural hematoma and head injury may cause dementia. Among these conditions, AD is being projected as one of the important memory disorder which calls for proper management.
The classic triad of senile plaques, neurofibrillary tangles and granulovascular degeneration are suggested to be pathogenic of AD. Clinical features include memory loss, difficulty in learning and retaining new information, depressive symptoms, aggression, agitation and disorders of perception.
With Parkinson's disease serving as the model for neurotransmitter replacement therapy, great expectations arose for analogous treatment success for victims of AD. Unfortunately, the results of replacement therapy have been notably disappointing. 
Keeping the above in view, a careful review has been done about the herbal recipes suggested by Ayurvedic classics in the management of disease called Vātavyādhi (nervous system disorders).
In addition to the above diseased condition an analysis has also been carried out about the memory enhancing drugs categorized under Medhya Rasāyana (memory rejuvenators) group of drugs.
| AD an Ayurvedic View|| |
There is no condition as described in Ayurveda which can be clinically equated to AD. But in Ayurvedic classics Smṛtināsha (loss of memory) is mentioned among the prodromal symptom of jarā (ageing).  In Jarāvasthā (old age), which starts from 60 years of age as per Caraka, Smṛti and other mental faculties gradually deteriorate naturally. As per Vāgbhaṭa (As.Sam.Sha 8/25) and Sharṅgadhara (Prathama Khaṇḍa 6/20), the functions of mind and Buddhi decline start declining from the 9 th decade of life. Mental function declines at 11 th decade of life as per Sharṅgadhara. Further, Smṛtibhramsha (disturbed memory) is described as a symptom where Smṛti (memory) is vitiated by rajas (passion) and tamas (obscurity).  Thus, senile dementia can be interpreted as Jarājanya Smṛtibhramsha according to Ayurvedic principles.  Ayurveda suggests Nasya karma (nasal administration) for all the Jatrugataroga (diseases of head and neck) which may have beneficial therapeutic effect in the patients of AD. Some of the important memory enhancing herbs mentioned in the ancient Ayurvedic literature is enumerated in [Table 1]. 
Herbs indicated in the treatment of Vātavyādhi (nervous system disorders)  which may help in restoration of declining memory are listed in [Table 2].
| Modern Scientific Validations of Herbal Memory Enhancers|| |
Certain medicinal plants and their combinations mentioned in Ayurvedic material medica have been evaluated in various experimental studies for their memory enhancing property are enumerated in [Table 3].
|Table 3a: Herbs found useful for Alzheimer's disease in experimental studies|
Click here to view
From the above list, the herbs which were subjected to extensive evaluation for their activity in the management of dementia are summarized below.
Brāhmī (Bacopa monieri)
Considerable number of studies (animal experiments and clinical trials) , have been done to evaluate its efficacy in learning and memory. It was concluded that Brāhmī has a positive effect on learning and both short-term and long-term memory. In a recent double-blind, placebo-controlled clinical trial,  the above findings were further proved and it was found that maximal effect was evident after 12 weeks of treatment. In another double blind randomized placebo control clinical study covering 76 adults aged 40-60 years and carried out over a 3 month period, it was concluded that the drug has significant beneficial action on retention of new information.  Saponins are considered as the active compounds.  Ethanolic extract of aerial parts and rhizome from the plant possessed nootropic activity.  It has been suggested that bacosides are able to induce membrane dephosphorylation with concomitant increase in protein and ribonucleic acid turnover in specific brain areas.  Other probable actions include: (1) Cognitive enhancement through modulatory effect on the cholinergic system,  (2) enhancement of protein kinase activity in hippocampus. 
Maṇḍūkaparṇī (Centella asiatica)
Maṇḍūkaparṇī is highly prized in Ayurvedic treatises as a Medhya (Memory and intellect promoting) and vayassthāpana (anti-ageing) drug. In Bhāvaprakāsha it has been stated that Maṇḍūkaparṇī and Brāhmī have very similar pharmacological activities.  A double blind clinical trial involving 30 mentally retarded children (age, 7-8 years) who received the drug (whole plant, dried in shade) for 3 months, showed improved cognitive function.  In recent investigations,  it was demonstrated that the aqueous extract of the plant (200 mg/kg, 14 days) improved learning and memory, in both the shuttle box and step through paradigms in male Wister rats. The extract was also found to be effective in preventing cognitive deficits in an intracerebroventricular Streptozotocin model of AD in rats. It is believed that an antioxidant mechanism is involved. Asiatic acid, the principal triterpinoid constituent of C. asiatica has been demonstrated to reduce hydrogen peroxide induced cell death and lower intracellular free radical concentration.  Asiatic acid has been patented (Hoechst Aktiengesellschaft) as a therapeutic agent for the treatment of dementia and this compound as well as some related synthetic analogues have been shown to protect cultured cortical neurons from glutamate-induced excite-toxicity.  Aqueous extract of the plant at a dose level of 300 mg/kg decreased the pentylenetetazole-kindled seizures in rats thus, indicating antiepileptic action of the herb.  The memory enhancing activity of C. asiatica may be due to Acetylcholinesterase inhibiting activity of asiatic acid and betulinic acid that can be potential lead for the symptomatic treatment of AD. 
Haridrā (Curcuma longa)
In Caraka Samhitā, Haridrā has been classified as curative of skin diseases (Kuṣṭhaghna), anti-obesity and scarifying (Lekhanīya), antidote to poisoning (Viśaghna) and has been recommended for the treatment of jaundice, cough, coryza, senility and impaired vision.  β-Amyloid induced oxidative stress appears to be an important pathway of neuronal cell death in AD. A bioassay guided fractionation of methanol (90%) extract of turmeric led to the isolation of calebin-A and the curcumins which effectively protected (in vitro) neuronal cells against β-Amyloid deposition.  In another study curcumin, on oral administration to alcohol-fed rats, caused a significant reversal of brain lipid peroxidation, thus indicating a neuro-protective role. 
| Discussion|| |
ācaryas of Ayurveda opine that Jarā (senility) is a natural disease (Svābhāvika vyādhi). Premature senility can be well-prevented by regular intake of Rasāyana or Vayassthāpana (longevity promoter) drugs. It is suggested to introduce Rasāyana drugs during young and middle phases of life. Ayurvedic classics document the decade wise decline in individuals and emphasized further that the decline of intelligence and memory starts at the end of 40 th year of the life.
In different phases of life, different dośas predominate: In the early part of life, kaphaja dośa (those arising out of biological humor which maintains structural integrity) predominates in the body; in the middle age, pitta (biological humor which resembles enzymatic and endocrinal functions) related diseases predominate and vāta (biological humor representing nervous system functions) dominance leads to degenerative changes during old age. Rasāyana drugs by their specific activity subdue the vitiated vāta and help in preserving the bodily physiological functions by restoring the feeling of well-being. Everybody is gifted with the capacity to regenerate destroyed cells. At the end of last century the scientists proved that damaged nerve cells can be regenerated contrary to the findings of earlier research studies. Caraka has identified Rāsnā (Pluchea lanceolata) as the prime drug for subduing vāta vitiation. Vāgbhaṭa has identified Lasuna (Allium sativum) as one of the prime drugs to curtail the pathological changes due to vāta dośa. It is also suggested that intake of Harītakī (Terminalia chebula) with different anupānas (vehicles) in different seasons not only helps to prevent seasonal diseases but also helps in regeneration of diseased cells. The combination of three fruits, i.e. Triphala (Three myrobalans) is suggested as one of the important Rasāyana group. Among Triphalā, Caraka identifies āmalaki (Emblica officinalis) to be the best fruit bestowed with Vayassthāpana activity (youth retaining activity). Both harītakī and āmalakī are attributed with Medhya property. Brāhmī and Maṇḍūkaparṇī share similar pharmacological properties. Caraka enumerates Maṇḍūkaparṇī among Medhya Rasāyanas while Vāgbhaṭa considers Brāhmī as a prime drug from apasmāra which is characterized by loss of Smṛti (memory) and saṃjρā (consciousness). Vāgbhaṭa also considers lasuna as the prime drug to treat vātavyādhi. During old age, body enters the phase of vāta dominance and vata decreases the asthi dhātu and the related majjā dhātu too. Brain tissue is referred as mastuluṅga majjā which goes into the degenerative phase due to interplay of excessive vata. In such conditions Lasūna in kalka dosage form as suggested by Sage Kaśyapa and Śodhala help to prevent degenerative changes in the brain. In a controlled clinical trial with Vayassthāpana group (8 out of 10 herbs suggested by Caraka) it was observed the volunteers who received vayassthāpana compound have shown improvement in the symptoms like anxiety and loss of concentration. 
| Conclusion|| |
Dementia pathologies such as AD are reaching epidemic proportions. They are not being successfully managed effectively by symptomatic treatments.  Currently, two centrally acting, reversible anti-cholinesterase drugs, tacrine and donepezil, are used to increase acetylcholine levels in the brain. Beneficial effects of the drugs are most notable in the early stages of the disease and lessen as the disease progresses.  There are many herbs from ethno-medicinal source which have been studied for their experimental potential in treating AD. A judicious combination of Ayurvedic methodology along with proved herbs from varied origin can be used in a in the management of AD.
| References|| |
Schernitski P, Bootman JL, Byers J, Likes K, Hughes JH. Demographic characteristics of elderly drug overdose patients admitted to a hospital emergency department. J Am Geriatr Soc 1980;28:544-6.
Nelson RC, Franzi LR, Nutrition and ageing, Geriatric medicine. In: The Medical Clinics of North America. Vol. 73. W.B. Saunders company, Philadelphia; 1989. p. 1531.
Katzman R. Editorial: The prevalence and malignancy of Alzheimer disease. A major killer. Arch Neurol 1976;33:217-8.
Terry RD, Davies P. Dementia of the Alzheimer type. Annu Rev Neurosci 1980;3:77-95.
Golwalla AF. Medicine for Students. Mumbai: The National Book Depot; 2003.
Germaine Louise Odenheimer Acquired cognitivedisorders of the elderly, Geriatricmedicine. In: The Medical Clinics of North America.Vol.73. W. B. Saunders company, 1989. p. 1405.
Upadhyaya Y. In: Nidan M, editor. Jararoga nidan 37/116. Varanasi: Chaukhambha Sanskrit Sansthan; 1993. p. 500-1.
Agnivesa. In: Acharya VJ, editor. 'Charak Samhita', revised by Charak and Dradhabala with 'Ayurved Dipika' commented by Chakrapanidatta. Cha.Sha. 1/101. Goapal Mandir Lane, Varanasi, India: Chaukhambha Surbharti Prakashan; 2005. p. 297.
Chaudhuri K, Samarakoon SM, Chandola HM, Kumar R, Ravishankar B. Evaluation of diet and life style in etiopathogenesis of senile dementia: A survey study. Ayu 2011;32:171-6.
Bhavmishra. Bhavprakasha Samhita edited with 'Vidyotini' Hindi comm. by Brahmasankara Mishra and Rupalalji Vaisya, Part II, Rasayana. Varanasi: Chaukhambha Sanskrit Bhawan; 2010;822-23.
Bhavmishra. Bhavprakasha Samhita edited with 'Vidyotini' Hindi comm. by Brahmasankara Mishra and Rupalalji Vaisya, Part II, Vatavyadhi. Varanasi: Chaukhambha Sanskrit Bhawan; 2010;227-72.
Datta C. Chakradatta of Chakrapani Datta, with 'Padarhtabodhini' Hindi Comm. By Vd. Ravidatta Sastri, Apasmaradhikar
21/11. Reprint. Varanasi: Chaukhambha Surbharti Prakashan; 2006. p. 90.
Vasudevan M, Parle M. Memory enhancing activity of Anwala churna (Emblica officinalis
Gaertn.): An Ayurvedic preparation. Physiol Behav 2007;91:46-54.
RaiKiranmai S. Neurogenic potential of Clitoriaternatea aqueous root extract - A basis for enhancing learning and memory, World academy of science, Engineering and technology 2010;4;10-22.
Dhuley JN. Nootropic-like effect of ashwagandha (Withania somnifera
L.) in mice. Phytother Res 2001;15:524-8.
Schliebs R, Liebmann A, Bhattacharya SK, Kumar A, Ghosal S, Bigl V. Systemic administration of defined extracts from Withania somnifera
(Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int 1997;30:181-90.
Sehgal N, Gupta A, Valli RK, Joshi SD, Mills JT, Hamel E, et al
. Withania somnifera
reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci U S A 2012;109:3510-5.
Dev S. A Selection of Prime Ayurvedic Plant Drugs-Ancient-Modern Concordance. New Delhi: Anamaya Publishers; 2006. p. 137.
Drever BD, Anderson WG, Riedel G, Kim DH, Ryu JH, Choi DY, et al
. The seed extract of Cassia obtusifolia
offers neuroprotection to mouse hippocampal cultures. J Pharmacol Sci 2008;107:380-92.
Kim DH, Yoon BH, Kim YW, Lee S, Shin BY, Jung JW, et al
. The seed extract of Cassia obtusifolia
ameliorates learning and memory impairments induced by scopolamine or transient cerebral hypoperfusion in mice. J Pharmacol Sci 2007;105:82-93.
Zhou H, Beevers CS, Huang S. The targets of curcumin. Curr Drug Targets 2011;12:332-47.
Lin MS, Hung KS, Chiu WT, Sun YY, Tsai SH, Lin JW, et al
. Curcumin enhances neuronal survival in N-methyl-d-aspartic acid toxicity by inducing RANTES expression in astrocytes via PI-3K and MAPK signaling pathways. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:931-8.
von Bohlen und Halbach O, Dermietzel R. Neurotransmitters and Neuromodulators. Weinheim, Germany: Wiley-VCH; 2002. p. 41.
Zhang Y, Shoyama Y, Sugiura M, Saito H. Effects of Crocus sativus
L. on the ethanol-induced impairment of passive avoidance performances in mice. Biol Pharm Bull 1994;17:217-21.
Dev S. A Selective of Prime Ayurvedic Plant Drugs (Ancient- Modern Concordance) Anamaya Publication, 2006. p. 100-102.
Dhanasekaran M, Holcomb LA, Hitt AR, Tharakan B, Porter JW, Young KA. et al
, Centella asiatica extract selectively decreases amyloid beta levels in hippocampus of Alzheimer's disease animal model. Phytother Res 2009;23;14-9.
Kim SR, Hwang SY, Jang YP, Park MJ, Markelonis GJ, Oh TH, et al
. Protopine from Corydalis ternata has anticholinesterase and antiamnesic activities. Planta Med 1999;65:218-21.
Preeti K, Rawat MSM, Comparative nootropic effect of Evolvulusalsinoides and Convolvulus pluricaulis. International Journal of Pharma and Bio Sciences 2011;2:1-16.
Ghosal S, Bhattacharya SK. Desmodium alkaloids. II. Chemical and pharmacological evaluation of D. gangeticum. Planta Med 1972;22:434-40.
Joshi H, Parle M. Antiamnesic effects of Desmodium gangeticum
in mice. Yakugaku Zasshi 2006;126:795-804.
Malik J, Karan M, Vasisht K. Nootropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi. Pharm Biol. 2011;49(12):1234-1242.
Ganguly R, Guha D. Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer's disease & protection by Moringa oleifera. Indian J Med Res 2008;128:744-51.
Ganguly R, Hazra R, Ray K, Guha D. Effect of Moringa oleiferain experimental model of Alzheimer's disease: Roleofantioxidants. Ann Neurosci 2005;12:36-9.
Mohan M, Kaul N, Punekar A, Girnar R, Junnare P, Patil L. Nootropicactivity of Moringa oleifera leaves. J Nat Remedies 2005;5:59-62.
Ghayur MN, Gilani AH, Ahmed T, Khalid A, Nawaz SA, Agbedahunsi JM, et al
. Muscarinic, Ca(++) antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia. J Pharm Pharmacol 2008;60:1375-83.
Obulesu M, Rao DM. Effect of plant extracts on Alzheimer's disease: An insight into therapeutic avenues. J Neurosci Rural Pract 2011;2:56-61.
Handa SS, Kaul MK, editors. Supplementto Cultivation and Utilization of Medicinal Plants. Jammu-Tawi, India: Regional Research Laboratory, Council of Scientific & Industrial Research; 1996. p. 515.
38 Lodha R, Bagga A. Traditional Indian systems of medicine. Ann Acad Med Singapore 2000;29:37-41.
Stough C, Lloyd J, Clarke J, Downey LA, Hutchison CW, Rodgers T, et al
. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl) 2001;156:481-4.
Roodenrys S, Booth D, Bulzomi S, Phipps A, Micallef C, Smoker J. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology 2002;27:279-81.
Billore KV, Yelne MB, Dennis TJ, Chaudhari BG. Database on Medicinal Plants Used in Ayurveda. Vol I. New Delhi: Central Council for Research in Ayurveda and Siddha; 2004.
Veerendra Kumar MH, Gupta YK. Effect of different extracts of Centella asiatica on cognition and markers of oxidative stress in rats. J Ethnopharmacol 2002;79:253-60.
Singh HK, Rastogi RP, Sriman RC, Dhavan BN. Effect of Bacoside A and B on avoidanace response in rats. Phytother Res 1988;2:70-5.
Stough C, Downey L, Lloyd J, Silber B, Redman S, Hutchison C, et al. Examining the nootropic effects of a special extract of Bacopamonniera on human cognitive functioning: 90 days double blind placebo controlled randomized trial. Phytother Res 2008;???:1-6.
Singh HK, Dhawan BN. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Indian J Pharmacol 1997;29:359-65.
Bhava Mishra, Chunekar KC, Commentator, Bhava Prakasha Nighantu, Guduchyadivarga 237, Revised and Enlarged edition. Varanasi: Chaukhambha Bharati Academy; 2010.
Appa Rao MV, Srinivasan K, Rao TK. The effect of Mandookaparni (Centellaasiatica) on the general mental ability (Medhya) of mentally retarded children. J Res Indian Med 1973;8;9-16.
Mook-Jung I, Shin JE, Yun SH, Huh K, Koh JY, Park HK, et al. Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity. J Neurosci Res 1999;58:417-25.
Lee MK, Kim SR, Sung SH, Lim D, Kim H, Choi H, et al. Asiatic acid derivatives protect cultured cortical neurons from glutamate-induced excitotoxicity. Res Commun Mol Pathol Pharmacol 2000;108:75-86.
Gupta YK, Veerendra Kumar MH, Srivastava AK. Effect of Centella asiatica on pentylenetetrazole-induced kindling, cognition and oxidative stress in rats. Pharmacol Biochem Behav 2003;74:579-85.
Orhan IE. Centellaasiatica (L) Urban, From traditional medicine to modern medicine with neuroprotective potential, Evid Based Complement Alternat Med 2012;2012;1-8.
Garg DS. Dhanwantari-Vanaushadhivishesh Anka. Vol.6. Vijaygard, Aligarh, India: Dhanvantari Karyalaya; 1971. p. 452.
Park SY, Kim DS. Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against Alzheimer's disease. J Nat Prod 2002;65:1227-31.
Rajakrishnan V, Viswanathan P, Rajasekharan KN, Menon VP. Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage. Phytother Res 1999;13:571-4.
Reddy DV, Nishteshwar K. Clinical evaluation of Rasayana effects of Charak's Vayasthapana Dashemani. Int J Res Ayurveda Pharm 2011;2:20-2.
Howes MJ, Perry E. The role of phytochemicals in the treatment and prevention of dementia. Drugs Aging 2011 1;28:439-68.
Nagle BT, Hitner H. Pharmacologyan Introduction. 5th ed.McGraw Hill; 2005. p. 76.
[Table 1], [Table 2], [Table 3]
|This article has been cited by|
||Gardenia jasminoides J.Ellis extract GJ-4 alleviated cognitive deficits of APP/PS1 transgenic mice
| ||Caixia Zang,Hui Liu,Junmei Shang,Hanyu Yang,Lu Wang,Chanjuan Sheng,Zihong Zhang,Xiuqi Bao,Yang Yu,Xinsheng Yao,Dan Zhang |
| ||Phytomedicine. 2021; : 153780 |
|[Pubmed] | [DOI]|
||Ameliorative Role of Nutraceuticals on Neurodegenerative Diseases Using the Drosophila melanogaster as a Discovery Model to Define Bioefficacy
| ||Ranjana Himalian,Sandeep Kumar Singh,Mahendra Pratap Singh |
| ||Journal of the American College of Nutrition. 2021; : 1 |
|[Pubmed] | [DOI]|
||Potential Ayurvedic Herbs for Neurodegenerative Diseases: A review
| ||Dipsundar Sahu,Shakti Bhushan,Debajyoti Das,Saroj Kumar Debnath,Laxmidhar Barik,Vandana Meena,Vikas Singh,Amit Kumar Dixit,PVV Prasad |
| ||Research Journal of Pharmacology and Pharmacodynamics. 2021; : 69 |
|[Pubmed] | [DOI]|
||Memory Enhancing Activity of Saraswatarishta in Mice
| ||Bhagyashri D. Rajopadhye,Ranjana A. Sahasrabudhe |
| ||Biomedical and Pharmacology Journal. 2020; 13(4): 2033 |
|[Pubmed] | [DOI]|
||Current Strategies and Novel Drug Approaches for Alzheimer Disease
| ||Roma Ghai, Kandasamy Nagarajan, Meenakshi Arora, Parul Grover, Nazakat Ali, Garima Kapoor |
| ||CNS & Neurological Disorders - Drug Targets. 2020; 19(9): 676 |
|[Pubmed] | [DOI]|
||From Ayurvedic folk medicine to preclinical neurotherapeutic role of a miraculous herb, Tinospora cordifolia
| ||Anuradha Sharma,Payal Bajaj,Anmol Bhandari,Gurcharan Kaur |
| ||Neurochemistry International. 2020; : 104891 |
|[Pubmed] | [DOI]|
||Functional foods for mental health promotion
| ||Soumam Dutta,Sohini Roy,Sanchari Roy |
| ||Journal of Mahatma Gandhi Institute of Medical Sciences. 2020; 25(2): 72 |
|[Pubmed] | [DOI]|
||Traditional Ayurvedic and herbal remedies for Alzheimer’s disease: from bench to bedside
| ||Rohit Sharma,Kamil Kuca,Eugenie Nepovimova,Atul Kabra,MM Rao,PK Prajapati |
| ||Expert Review of Neurotherapeutics. 2019; : 1 |
|[Pubmed] | [DOI]|
||Alzheimer Disease: Clues from traditional and complementary medicine
| ||Edwin L. Cooper,Melissa J. Ma |
| ||Journal of Traditional and Complementary Medicine. 2017; |
|[Pubmed] | [DOI]|
||Natural products against Alzheimerćs disease: Pharmaco-therapeutics and biotechnological interventions
| ||Abhijit Dey,Raktim Bhattacharya,Anuradha Mukherjee,Devendra Kumar Pandey |
| ||Biotechnology Advances. 2016; |
|[Pubmed] | [DOI]|
||Antifungal and Anticancer Potential of Argemone mexicana L.
| ||Nilesh More,Arun Kharat |
| ||Medicines. 2016; 3(4): 28 |
|[Pubmed] | [DOI]|